SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-30
👔
BioCardia, Inc.
@BCDA_InsiderForm 4 Filing: Altman Peter Buys $3,900 of $BCDA
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
BioCardia, Inc.
Ticker: $BCDA
Transaction Value
$3,900
Price/Share: $0.78
transaction date
2026-07-29
Shares: 5,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Altman Peter, holds the title of President and CEO at BioCardia, Inc..
On 2026-07-29, the insider transacted 5,000 shares.The shares were transacted at a weighted average price of $0.78 per share, resulting in a total market-relevant value of $3,900.
Executive Summary Summary
Altman Peter (President and CEO) bought $4K of $BCDA
Post-Transaction Position: 373,885 shares
SEC Accession No: 0001437749-26-024925 (CIK: 1647542)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.